| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.9 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |